1. Enterovirus virus-like-particle and inactivated poliovirus vaccines do not elicit substantive cross-reactive antibody responses.
- Author
-
Moss DL, Paine AC, Krug PW, Kanekiyo M, and Ruckwardt TJ
- Subjects
- Animals, Mice, Vaccines, Virus-Like Particle immunology, Antibodies, Neutralizing immunology, Papio immunology, Humans, Poliovirus immunology, Female, Antibody Formation immunology, Enterovirus immunology, Mice, Inbred BALB C, Enterovirus D, Human immunology, Cross Reactions immunology, Antibodies, Viral immunology, Enterovirus Infections immunology, Enterovirus Infections prevention & control, Enterovirus Infections virology, Poliovirus Vaccine, Inactivated immunology, Poliovirus Vaccine, Inactivated administration & dosage
- Abstract
Human enteroviruses are the most common human pathogen with over 300 distinct genotypes. Previous work with poliovirus has suggested that it is possible to generate antibody responses in humans and animals that can recognize members of multiple enterovirus species. However, cross protective immunity across multiple enteroviruses is not observed epidemiologically in humans. Here we investigated whether immunization of mice or baboons with inactivated poliovirus or enterovirus virus-like-particles (VLPs) vaccines generates antibody responses that can recognize enterovirus D68 or A71. We found that mice only generated antibodies specific for the antigen they were immunized with, and repeated immunization failed to generate cross-reactive antibody responses as measured by both ELISA and neutralization assay. Immunization of baboons with IPV failed to generate neutralizing antibody responses against enterovirus D68 or A71. These results suggest that a multivalent approach to enterovirus vaccination is necessary to protect against enterovirus disease in vulnerable populations., Competing Interests: The authors have declared that no competing interests exist., (Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.)
- Published
- 2024
- Full Text
- View/download PDF